UBS Group AG - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 31 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$2,000
-50.0%
10,000
-17.8%
0.00%
Q4 2017$4,000
-77.8%
12,170
-64.2%
0.00%
Q3 2017$18,000
+5.9%
33,995
+15.3%
0.00%
Q2 2017$17,000
+240.0%
29,484
+492.6%
0.00%
Q2 2016$5,000
-50.0%
4,975
-19.9%
0.00%
Q4 2015$10,000
+400.0%
6,211
+539.6%
0.00%
Q3 2015$2,000971
+48450.0%
0.00%
Q2 2015$0
-100.0%
2
-99.6%
0.00%
Q1 2015$2,0004950.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Prospera Financial Services Inc 167,600$126,0000.02%
HighTower Advisors, LLC 1,037,871$540,0000.01%
MCIA Inc 5,300$3,0000.00%
TWO SIGMA SECURITIES, LLC 51,190$27,0000.00%
Virtu Financial LLC 31,902$17,0000.00%
INGALLS & SNYDER LLC 20,739$11,0000.00%
BDO Wealth Advisors, LLC 3,000$2,0000.00%
Perigon Wealth Management, LLC 9$00.00%
Balentine LLC 55$00.00%
Capital Advisors, Ltd. LLC 177$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders